169 related articles for article (PubMed ID: 2572264)
1. Contrasting effects of single doses of pindolol and xamoterol on left ventricular diastolic function.
Rousseau MF; Pouleur H; Debaisieux JC; Van Eyll C; Charlier AA
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):84S-85S. PubMed ID: 2572264
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
3. Selective beta-adrenoceptor partial agonist effects of pindolol and xamoterol on skeletal muscle assessed by plasma creatine kinase changes in healthy subjects.
Tomlinson B; Cruickshank JM; Hayes Y; Renondin JC; Lui JB; Graham BR; Jones A; Lewis AD; Prichard BN
Br J Clin Pharmacol; 1990 Nov; 30(5):665-72. PubMed ID: 1980200
[TBL] [Abstract][Full Text] [Related]
4. Haemodynamics in postural hypotension--effects of the beta-adrenoceptor partial agonist xamoterol, and pindolol.
Mehlsen J; Trap-Jensen J
Eur Heart J; 1990 Apr; 11 Suppl A():56-8. PubMed ID: 1971593
[TBL] [Abstract][Full Text] [Related]
5. Acute haemodynamic effects of the beta 1-adrenoceptor partial agonist xamoterol at rest and during supine exercise in patients with left ventricular dysfunction due to ischaemic heart disease: a double-blind randomized trial.
de Feyter PJ; Serruys PW
Eur Heart J; 1990 Apr; 11 Suppl A():48-9. PubMed ID: 1971590
[TBL] [Abstract][Full Text] [Related]
6. Effects of long-term xamoterol therapy on the left ventricular mechanical efficiency in patients with ischemic heart disease.
Pouleur H; van Eyll C; Etienne J; van Mechelen H; Vuylsteke A; Rousseau MF
Basic Res Cardiol; 1989; 84 Suppl 1():157-62. PubMed ID: 2573338
[TBL] [Abstract][Full Text] [Related]
7. Effects of xamoterol on inotropic and lusitropic properties of the human myocardium and on adenylate cyclase activity.
Böhm M; Mittmann C; Schwinger RH; Erdmann E
Am Heart J; 1990 Dec; 120(6 Pt 1):1381-92. PubMed ID: 1978979
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of xamoterol on left ventricular diastolic function and late remodeling: a study in patients with anterior myocardial infarction and single-vessel disease.
Pouleur H; van Eyll C; Hanet C; Cheron P; Charlier AA; Rousseau MF
Circulation; 1988 May; 77(5):1081-9. PubMed ID: 2896076
[TBL] [Abstract][Full Text] [Related]
9. The electrophysiological effects of intravenous xamoterol in man.
Bowes RJ; Gautam PC; Graham DR; Harley A
Eur J Clin Pharmacol; 1986; 29(6):731-4. PubMed ID: 2872057
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.
Hattori Y; Sakuma I; Nakao Y; Kanno M
J Pharmacol Exp Ther; 1987 Sep; 242(3):1077-85. PubMed ID: 2888870
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience of therapy with xamoterol in patients with severe systolic and diastolic dysfunction.
Pouleur H; Hanet C; Rousseau MF
Eur Heart J; 1990 Apr; 11 Suppl A():33-8. PubMed ID: 1971587
[TBL] [Abstract][Full Text] [Related]
12. Illustration of the effects of long-term xamoterol therapy on the time course of left ventricular pressure.
van Mechelen H; Ries A; Pouleur H; Rousseau MF
Eur Heart J; 1990 Apr; 11 Suppl A():67-9. PubMed ID: 1971598
[TBL] [Abstract][Full Text] [Related]
13. The cardiovascular pharmacology of xamoterol, cicloprolol, prenalterol and pindolol in the anaesthetised dog.
Hadfield SE; Slee SJ; Snow HM
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):78S-81S. PubMed ID: 2572262
[TBL] [Abstract][Full Text] [Related]
14. The in vitro pharmacology of xamoterol (ICI 118,587).
Malta E; Mian MA; Raper C
Br J Pharmacol; 1985 May; 85(1):179-87. PubMed ID: 2862938
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of beta-adrenoceptor partial agonists in patients with postural hypotension.
Mehlsen J; Stadeager C; Trap-Jensen J
Eur J Clin Pharmacol; 1993; 44(1):7-11. PubMed ID: 8436159
[TBL] [Abstract][Full Text] [Related]
16. Beta, partial agonists to treat heart failure: effects of xamoterol upon cardiac function and clinical status.
Heng MK
Clin Cardiol; 1990 Mar; 13(3):171-6. PubMed ID: 1969783
[TBL] [Abstract][Full Text] [Related]
17. Immediate central and regional haemodynamic effects of a new beta 1-adrenergic stimulating drug, xamoterol (Corwin) in healthy volunteers.
Tangø M; Carlsen JE; Trap-Jensen J
Eur J Clin Pharmacol; 1985; 29(2):155-8. PubMed ID: 2866963
[TBL] [Abstract][Full Text] [Related]
18. A comparative study on the ventilatory and haemodynamic effects of xamoterol and atenolol in asthmatic patients.
Lammers JW; Müller ME; Folgering HT; van Herwaarden CL
Br J Clin Pharmacol; 1986 Nov; 22(5):595-602. PubMed ID: 2878680
[TBL] [Abstract][Full Text] [Related]
19. Cardiac effects of beta-adrenoceptor antagonists with intrinsic sympathomimetic activity in humans: beta1- and/or beta2-adrenoceptor mediated?
Jakubetz J; Schmuck S; Poller U; Fuchs B; Gorf A; Radke J; Pönicke K; Brodde OE
J Cardiovasc Pharmacol; 1999 Mar; 33(3):461-72. PubMed ID: 10069683
[TBL] [Abstract][Full Text] [Related]
20. [Role of adrenergic beta receptor partial agonists in left ventricular failure of ischemic origin. Value of xamoterol (ICI 118,587, Corwin)].
Rousseau MF; Cheron P; Nannan M; Vincent MF; Lavenne F; Pouleur H
Ann Med Interne (Paris); 1985; 136(3):247-50. PubMed ID: 2862823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
